Antiretroviral treatment leading to secondary trimethylaminuria: Genetic associations and successful management with riboflavin.

Concetta ScimoneSimona AlibrandiLuigi DonatoSalvatore V GiofrèGiacomo RaoAntonina SidotiRosalia D'Angelo

Published in: Journal of clinical pharmacy and therapeutics (2020)

Antiretrovirals may increase the concentration of TMA precursors. The present study reports antiretroviral treatment as risk factor for such secondary trimethylaminuria. Riboflavin is an effective treatment.

Keyphrases

human immunodeficiency virus
emergency department
hiv aids
genome wide
hiv positive
men who have sex with men
smoking cessation
drug induced
electronic health record